Clinical trial
A Multicenter, Randomized, Double-Blind, Flexible-Dose, Long-Term Extension Trial of the Safety and Maintenance of Effect of Asenapine Using Haloperidol Positive Control in Subjects Who Complete Protocol 041023 [NCT00156104]
NCT00156065 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-Blind, Flexible-Dose, Long-Term Extension Trial of the Safety and Maintenance of Effect of Asenapine Using Haloperidol Positive Control in Subjects Who Complete Protocol 041023 [NCT00156104]
- Lead sponsor
- Organon and Co
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2005
- Completion date
- October 31, 2007
- Enrollment
- 187 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.